Thought Leadership
September Roundup: Biosimilar Policy Recommendations, Clinical Developments, and Interviews
September 27, 2021
Editors
The Center for Biosimilars

Axinn partner Chad Landmon was quoted in The Center for Biosimilars article, "September Roundup: Biosimilar Policy Recommendations, Clinical Developments, and Interviews."

Click here to access the article.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.